What is Biomx (Nyse: Phge)'s official website?

Biomx (Nyse: Phge)'s website is biomx.com

How many employees are working in Biomx (Nyse: Phge) right now?

Biomx (Nyse: Phge) has 64 employees.

What is Biomx (Nyse: Phge)'s industry?

Biomx (Nyse: Phge)'s industry is Biotechnology Research

Who are Biomx (Nyse: Phge)'s top competitors?

Biomx (Nyse: Phge)'s top competitors are , , , , , ,

Biomx (Nyse: Phge) company information, Employees & Contact Information

Explore related pages

Biomx (Nyse: Phge) email format Biomx (Nyse: Phge) management contacts

Related company profiles:

BiomX (NYSE America: PHGE) is developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets.

Employees: 64
Founded: -
Address: 708 Quince Orchard Rd, Gaithersburg,maryland 20878,united States
Phone: 97289553100
Email: in****@****omx.com
Industry: Biotechnology Research
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)
Website: biomx.com
Keywords: Microbiome, Biotechnology, Drug Discovery, Phage Therapies, Pharma.
HQ: Gaithersburg, Maryland
Competitors: NeuroKaire (formerly Genetika+), Evogene, Pluri, Lavie Bio, Anima Biotech, Immunai, Nucleai, MeMed, Converge Bio, CytoReason.

Biomx (Nyse: Phge) Questions

News

BiomX CEO to Present at H.C. Wainwright 27th Annual Global Investment Conference - Yahoo Finance

BiomX CEO to Present at H.C. Wainwright 27th Annual Global Investment Conference Yahoo Finance

BiomX Provides a Program Update and Announces New FDA Feedback Potentially Expanding BX004 Development Pathways - Sahm

BiomX Provides a Program Update and Announces New FDA Feedback Potentially Expanding BX004 Development Pathways Sahm

BiomX Earnings: Novel Phage Therapy Pioneer Reveals Q2 2025 Results and Pipeline Progress - Stock Titan

BiomX Earnings: Novel Phage Therapy Pioneer Reveals Q2 2025 Results and Pipeline Progress Stock Titan

BiomX to Report Second Quarter 2025 Financial Results and Program Updates on August 13, 2025 - GlobeNewswire

BiomX to Report Second Quarter 2025 Financial Results and Program Updates on August 13, 2025 GlobeNewswire

BiomX Inc. to Report Q4 and Full Year 2024 Financial Results on March 25, 2025 - Nasdaq

BiomX Inc. to Report Q4 and Full Year 2024 Financial Results on March 25, 2025 Nasdaq

BiomX Reports Second Quarter 2025 Financial Results and Provides Program Updates - Yahoo Finance

BiomX Reports Second Quarter 2025 Financial Results and Provides Program Updates Yahoo Finance

BiomX Inc. Initiates First Patient Dosing in Phase 2b Trial for BX004 Targeting Antibiotic-Resistant Lung Infections in Cystic Fibrosis Patients - Nasdaq

BiomX Inc. Initiates First Patient Dosing in Phase 2b Trial for BX004 Targeting Antibiotic-Resistant Lung Infections in Cystic Fibrosis Patients Nasdaq

BiomX Announces Positive Topline Results from Phase 2 Trial - GlobeNewswire

BiomX Announces Positive Topline Results from Phase 2 Trial GlobeNewswire

BiomX Announces Publication in Nature Communications of Phage Cocktail BX004 Phase 1b/2a Part 1 Data Demonstrating Strong Activity in Cystic Fibrosis - Yahoo Finance

BiomX Announces Publication in Nature Communications of Phage Cocktail BX004 Phase 1b/2a Part 1 Data Demonstrating Strong Activity in Cystic Fibrosis Yahoo Finance

Nature Communications Validates BiomX's Breakthrough: 500-fold Bacteria Reduction in Cystic Fibrosis Trial - Stock Titan

Nature Communications Validates BiomX's Breakthrough: 500-fold Bacteria Reduction in Cystic Fibrosis Trial Stock Titan

BiomX Reports First Quarter 2025 Financial Results and Provides Business and Program Updates - GlobeNewswire

BiomX Reports First Quarter 2025 Financial Results and Provides Business and Program Updates GlobeNewswire

BiomX Inc. Announces 1-for-10 Reverse Stock Split - Yahoo Finance

BiomX Inc. Announces 1-for-10 Reverse Stock Split Yahoo Finance

BiomX Announces Entry into Merger Agreement with Adaptive Phage Therapeutics and Concurrent $50 Million Financing - Yahoo Finance

BiomX Announces Entry into Merger Agreement with Adaptive Phage Therapeutics and Concurrent $50 Million Financing Yahoo Finance

BiomX Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards - Yahoo Finance

BiomX Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards Yahoo Finance

BiomX Announces Closing of the Acquisition of Adaptive Phage Therapeutics and Concurrent $50 Million Financing - Yahoo Finance

BiomX Announces Closing of the Acquisition of Adaptive Phage Therapeutics and Concurrent $50 Million Financing Yahoo Finance

BiomX Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business and Program Updates - Yahoo Finance

BiomX Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business and Program Updates Yahoo Finance

BiomX Reports Second Quarter 2024 Financial Results and Provides Business and Program Updates - Yahoo Finance

BiomX Reports Second Quarter 2024 Financial Results and Provides Business and Program Updates Yahoo Finance

BiomX Inc. Announces NYSE American Acceptance of Plan to Regain Listing Compliance - GlobeNewswire

BiomX Inc. Announces NYSE American Acceptance of Plan to Regain Listing Compliance GlobeNewswire

NYSE American Initiates Delisting Proceedings for BiomX Warrants - Yahoo Finance

NYSE American Initiates Delisting Proceedings for BiomX Warrants Yahoo Finance

Topline results Q1 2026: BiomX's BX004 Phase 2b on track; FDA offers new development pathways - Stock Titan

Topline results Q1 2026: BiomX's BX004 Phase 2b on track; FDA offers new development pathways Stock Titan

BiomX Announces Corporate Restructuring - Business Wire

BiomX Announces Corporate Restructuring Business Wire

BiomX to Host Second Quarter 2023 Financial Results Conference Call and Webcast on August 9th, 2023 - Stock Titan

BiomX to Host Second Quarter 2023 Financial Results Conference Call and Webcast on August 9th, 2023 Stock Titan

BiomX Reports Third Quarter 2022 Financial Results and Provides Business Update - GlobeNewswire

BiomX Reports Third Quarter 2022 Financial Results and Provides Business Update GlobeNewswire

Earnings call: BiomX reports Q2 2024 financials, clinical updates - Investing.com

Earnings call: BiomX reports Q2 2024 financials, clinical updates Investing.com

BiomX to Host Second Quarter 2022 Financial Results Conference Call and Webcast on August 10, 2022 - FinancialContent

BiomX to Host Second Quarter 2022 Financial Results Conference Call and Webcast on August 10, 2022 FinancialContent

Development of a topical bacteriophage gel targeting Cutibacterium acnes for acne prone skin and results of a phase 1 cosmetic randomized clinical trial - Golembo - 2022 - Skin Health and Disease - Wiley Online Library

Development of a topical bacteriophage gel targeting Cutibacterium acnes for acne prone skin and results of a phase 1 cosmetic randomized clinical trial - Golembo - 2022 - Skin Health and Disease Wiley Online Library

BiomX Presenting at Three Upcoming Investor Conferences - FinancialContent

BiomX Presenting at Three Upcoming Investor Conferences FinancialContent

PHGE - Biomx Inc Latest Stock News & Market Updates - Stock Titan

PHGE - Biomx Inc Latest Stock News & Market Updates Stock Titan

PHGE Stock Price and Chart — AMEX:PHGE - TradingView

PHGE Stock Price and Chart — AMEX:PHGE TradingView

Companies like Biomx (Nyse: Phge)

Top Biomx (Nyse: Phge) Employees

Yaron Tzur

Associate Director Of Pharmaceutical…

Israel, Israel

View

2
gmail.com, biomx.com
Regis A. Vilchez, MD, PhD

Physician Scientist / Global…

Greater Houston, United States, United States

View

5
biomx.com, mallinckrodt.com, yahoo.com, spcorp.com, micurx.com
Greg Merril

n/a

Bethesda, Maryland, United States, United States

View

12
brainsentry.com, ia-labs.com, pwrgrid.com, yostlabs.com, yeitechnology.com, decision-tech.com, actiongms.com, bellsouth.net, cs.com, aol.com, aphage.com, yostlabs.com

3 +124089XXXXX
Chris Jennings

Contract Regulatory Medical Writer

Greater Boston, United States

View

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles

Get direct phone numbers & mobile contacts

Access company data & employee information

Works directly on LinkedIn - no copy/paste needed

Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Learn More

How It Works

Get a Free Account

Search the #1 Contact Database

Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.

Use our AI-Powered Email Finder

Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.

Have a look at Aeroleads Data

Browse our Data

Company Search

a b c d e f g h i j k l m n o p q r s t u v w x y z

Profile Search

a b c d e f g h i j k l m n o p q r s t u v w x y z

List Search

a b c d e f g h i j k l m n o p q r s t u v w x y z

Biomx (Nyse: Phge) company information, Employees & Contact Information

Explore related pages

Company Details

Biomx (Nyse: Phge) Questions

What is Biomx (Nyse: Phge)'s helpline number?

What is Biomx (Nyse: Phge)'s official website?

What is Biomx (Nyse: Phge)'s LinkedIn profile?

How many employees are working in Biomx (Nyse: Phge) right now?

What is Biomx (Nyse: Phge)'s industry?

What are Biomx (Nyse: Phge)'s top competitors?

What is Biomx (Nyse: Phge)'s support email address?

What are Biomx (Nyse: Phge)'s categories?

When was Biomx (Nyse: Phge) founded?

News

BiomX CEO to Present at H.C. Wainwright 27th Annual Global Investment Conference - Yahoo Finance

BiomX Provides a Program Update and Announces New FDA Feedback Potentially Expanding BX004 Development Pathways - Sahm

BiomX Earnings: Novel Phage Therapy Pioneer Reveals Q2 2025 Results and Pipeline Progress - Stock Titan

BiomX to Report Second Quarter 2025 Financial Results and Program Updates on August 13, 2025 - GlobeNewswire

BiomX Inc. to Report Q4 and Full Year 2024 Financial Results on March 25, 2025 - Nasdaq

BiomX Reports Second Quarter 2025 Financial Results and Provides Program Updates - Yahoo Finance

BiomX Inc. Initiates First Patient Dosing in Phase 2b Trial for BX004 Targeting Antibiotic-Resistant Lung Infections in Cystic Fibrosis Patients - Nasdaq

BiomX Announces Positive Topline Results from Phase 2 Trial - GlobeNewswire

BiomX Announces Publication in Nature Communications of Phage Cocktail BX004 Phase 1b/2a Part 1 Data Demonstrating Strong Activity in Cystic Fibrosis - Yahoo Finance

Nature Communications Validates BiomX's Breakthrough: 500-fold Bacteria Reduction in Cystic Fibrosis Trial - Stock Titan

BiomX Reports First Quarter 2025 Financial Results and Provides Business and Program Updates - GlobeNewswire

BiomX Inc. Announces 1-for-10 Reverse Stock Split - Yahoo Finance

BiomX Announces Entry into Merger Agreement with Adaptive Phage Therapeutics and Concurrent $50 Million Financing - Yahoo Finance

BiomX Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards - Yahoo Finance

BiomX Announces Closing of the Acquisition of Adaptive Phage Therapeutics and Concurrent $50 Million Financing - Yahoo Finance

BiomX Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business and Program Updates - Yahoo Finance

BiomX Reports Second Quarter 2024 Financial Results and Provides Business and Program Updates - Yahoo Finance

BiomX Inc. Announces NYSE American Acceptance of Plan to Regain Listing Compliance - GlobeNewswire

NYSE American Initiates Delisting Proceedings for BiomX Warrants - Yahoo Finance

Topline results Q1 2026: BiomX's BX004 Phase 2b on track; FDA offers new development pathways - Stock Titan

BiomX Announces Corporate Restructuring - Business Wire

BiomX to Host Second Quarter 2023 Financial Results Conference Call and Webcast on August 9th, 2023 - Stock Titan

BiomX Reports Third Quarter 2022 Financial Results and Provides Business Update - GlobeNewswire

Earnings call: BiomX reports Q2 2024 financials, clinical updates - Investing.com

BiomX to Host Second Quarter 2022 Financial Results Conference Call and Webcast on August 10, 2022 - FinancialContent

Development of a topical bacteriophage gel targeting Cutibacterium acnes for acne prone skin and results of a phase 1 cosmetic randomized clinical trial - Golembo - 2022 - Skin Health and Disease - Wiley Online Library

BiomX Presenting at Three Upcoming Investor Conferences - FinancialContent

PHGE - Biomx Inc Latest Stock News & Market Updates - Stock Titan

PHGE Stock Price and Chart — AMEX:PHGE - TradingView

Companies like Biomx (Nyse: Phge)

Immunai

Memed

Cytoreason

Pluri

Lavie Bio

Anima Biotech

Evogene

Nucleai

Converge Bio

Neurokaire (Formerly...

Top Biomx (Nyse: Phge) Employees

Yaron Tzur

Associate Director Of Pharmaceutical…

Regis A. Vilchez, MD, PhD

Physician Scientist / Global…

Greg Merril

n/a

Chris Jennings

Contract Regulatory Medical Writer

Free Chrome Extension

Aero Online

Select data to include:

How It Works

Get a Free Account

Search the #1 Contact Database

Use our AI-Powered Email Finder

Have a look at Aeroleads Data